CB1R antagonism offers proven therapeutic benefits in multiple metabolic diseases, such as obesity, diabetes, and dyslipidemia, and fibrotic disorders of the liver, heart, kidney, skin, and lung (6). This evidence concerns the gene CNR1 and metabolic syndrome.